Sweden· SE-19930219000035
Retrovir 10 mg/ml Koncentrat till infusionsvätska, lösning
A medicinal product containing zidovudine, registered in Sweden by ViiV Healthcare BV.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Zidovudine
- Manufacturer
- ViiV Healthcare BV
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19930219000035
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Zidovudine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaRETROVIRViiV Healthcare BV, Amersfoort
- IrelandRetrovir 10 mg/ml IV concentrate for solution for infusionViiV Healthcare BV
- NorwayRetrovirViiV Healthcare BV
- PolandRetrovirViiV Healthcare BV
- BelgiumCombivir 150 mg - 300 mgViiV Healthcare
- United KingdomRetrovir 100mg capsulesViiV Healthcare UK Ltd
- United StatesRETROVIRViiV Healthcare Company
- GermanyRetrovirViiv Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Retrovir
- Belgium · Retrovir, Retrovir I.V.
- Bulgaria · Ретровир
- Czechia · Retrovir
- Germany · Retrovir, Retrovir I.V.
- Denmark · Retrovir
- Estonia · Retrovir
- Spain · Retrovir, Zidovudina Accord
- Finland · Retrovir
- France · Retrovir
- United Kingdom (Northern Ireland) · Retrovir, Retrovir Iv
- Greece · Retrovir
- Ireland · Retrovir
- Italy · Retrovir
- Luxembourg · Retrovir, Retrovir I.V.
- Netherlands · Retrovir, Retrovir Infuus
- Poland · Retrovir
- Portugal · Retrovir, Retrovir Iv
- Romania · Retrovir
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e44cc481-1844-4f72-b265-bb89ee273a3a GET /v1/drugs/e44cc481-1844-4f72-b265-bb89ee273a3a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL",
"Dispensbeslut"
],
"se_npl_id": "19930219000035",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19930219000035",
"product_doc_link": "https://docetp.mpa.se/LMF/Retrovir%20concentrate%20for%20solution%20for%20infusion%20SmPC_09001bee807a7409.pdf"
}See everything about zidovudine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.